Richard Croy

589 total citations
9 papers, 409 citations indexed

About

Richard Croy is a scholar working on Transplantation, Surgery and Oncology. According to data from OpenAlex, Richard Croy has authored 9 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Transplantation, 4 papers in Surgery and 3 papers in Oncology. Recurrent topics in Richard Croy's work include Renal Transplantation Outcomes and Treatments (5 papers), Transplantation: Methods and Outcomes (3 papers) and Polyomavirus and related diseases (3 papers). Richard Croy is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Transplantation: Methods and Outcomes (3 papers) and Polyomavirus and related diseases (3 papers). Richard Croy collaborates with scholars based in United States, Netherlands and Japan. Richard Croy's co-authors include M. Roy First, John Holman, E. Steve Woodle, V. Ram Peddi, Michael J. Hanaway, Dixon B. Kaufman, Shamkant Mulgaonkar, William E. Fitzsimmons, Shobha Dhadda and Harold C. Yang and has published in prestigious journals such as New England Journal of Medicine, Transplantation and The Journal of Heart and Lung Transplantation.

In The Last Decade

Richard Croy

8 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard Croy United States	6	313	153	78	73	72	9	409
Samir J. Patel United States	9	263 0.8×	140 0.9×	49 0.6×	58 0.8×	46 0.6×	19	390
Luiz E. Ianhez Brazil	13	190 0.6×	119 0.8×	98 1.3×	46 0.6×	58 0.8×	18	422
Rebecca Shi United States	8	252 0.8×	102 0.7×	48 0.6×	111 1.5×	23 0.3×	8	360
K. Gillingham United States	10	525 1.7×	354 2.3×	136 1.7×	91 1.2×	55 0.8×	16	633
M.R. Laftavi United States	14	370 1.2×	268 1.8×	122 1.6×	62 0.8×	54 0.8×	48	530
Rajil Mehta United States	14	430 1.4×	264 1.7×	169 2.2×	94 1.3×	41 0.6×	36	544
Antonio Franco Spain	11	236 0.8×	94 0.6×	51 0.7×	98 1.3×	79 1.1×	42	398
Basma Sadaka United States	9	372 1.2×	161 1.1×	52 0.7×	40 0.5×	30 0.4×	11	441
J. Stevenson Bynon United States	14	355 1.1×	400 2.6×	101 1.3×	91 1.2×	43 0.6×	17	559
J.R. Salaman United Kingdom	12	168 0.5×	196 1.3×	108 1.4×	121 1.7×	74 1.0×	36	511

Countries citing papers authored by Richard Croy

Since Specialization

Citations

This map shows the geographic impact of Richard Croy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Croy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Croy more than expected).

Fields of papers citing papers by Richard Croy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Croy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Croy. The network helps show where Richard Croy may publish in the future.

Co-authorship network of co-authors of Richard Croy

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Croy. A scholar is included among the top collaborators of Richard Croy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Croy. Richard Croy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Croy, Richard, et al.. (2023). Pediatric Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Retrospective Cohort Study Using Real-World Evidence From the US Scientific Registry of Transplant Recipients. Transplantation Proceedings. 55(7). 1692–1705. 1 indexed citations

Croy, Richard, et al.. (2022). Lung Transplant Outcomes in Adults in the United States: Retrospective Cohort Study Using Real-world Evidence from the SRTR. Transplantation. 106(6). 1233–1242. 10 indexed citations

Till, J. W. Olivier van, Eri Arita, Richard Croy, et al.. (2022). Muscarinic‐3‐receptor positive allosteric modulator ASP8302 in patients with underactive bladder. A randomized controlled trial. Neurourology and Urodynamics. 41(5). 1139–1148. 7 indexed citations

Croy, Richard, et al.. (2021). Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Data from the US Scientific Registry of Transplant Recipients (SRTR). The Journal of Heart and Lung Transplantation. 40(4). S165–S165.

Tedesco‐Silva, Hélio, Harold C. Yang, Herwig‐Ulf Meier‐Kriesche, et al.. (2014). Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients. Transplantation. 97(6). 636–641. 63 indexed citations

First, M. Roy, Shobha Dhadda, Richard Croy, John Holman, & William E. Fitzsimmons. (2013). New-Onset Diabetes After Transplantation (NODAT). Transplantation. 96(1). 58–64. 52 indexed citations

Hanaway, Michael J., E. Steve Woodle, Shamkant Mulgaonkar, et al.. (2011). Alemtuzumab Induction in Renal Transplantation. New England Journal of Medicine. 364(20). 1909–1919. 252 indexed citations

Dhadda, Shobha, William E. Fitzsimmons, Richard Croy, John Holman, & M. Roy First. (2010). DEFINING NEW-ONSET DIABETES AFTER TRANSPLANTATION (NODAT).. Transplantation. 90. 694–694. 1 indexed citations

Krueger, Gerald G., Lawrence F. Eichenfield, J. John Goodman, et al.. (2007). Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitis.. PubMed. 6(2). 185–93. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact